재택 화학요법 서비스 시장 규모, 점유율, 성장 분석 : 서비스 유형별, 치료 모델별, 암 유형별, 서비스 프로바이더별, 지불 모델별, 지역별 - 산업 예측(2026-2033년)

Global Chemotherapy At Home Services Market size was valued at USD 3.25 Billion in 2024 and is poised to grow from USD 3.54 Billion in 2025 to USD 7.01 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The global chemotherapy-at-home services market is witnessing significant growth due to an aging cancer patient demographic and the increasing shift towards outpatient care. Factors such as reduced hospital readmissions from U.S. pilot programs and European reimbursement models for home infusion are driving adoption. The pandemic heightened demand, as patients preferred to avoid facilities, prompting insurers to broaden coverage. This market is transitioning from specialty clinics to an integral part of oncology, with health platforms optimizing drug preparation and monitoring. Automation through AI technologies is enhancing patient safety and operational efficiency by enabling real-time treatment adjustments and reducing medication errors. Consequently, insurers are reassessing coverage, further promoting home-based chemotherapy as an effective and safe alternative to traditional hospital settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chemotherapy At Home Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chemotherapy At Home Services Market Segments Analysis

Global chemotherapy at home services market is segmented by service type, care model, cancer type, service provider, payment model and region. Based on service type, the market is segmented into Home Infusion Chemotherapy, Oral Chemotherapy Management, Home-Based Supportive Care and Other Home Chemotherapy Services. Based on care model, the market is segmented into Nurse-Led Home Care, Physician-Supervised Home Care and Integrated Home Oncology Care. Based on cancer type, the market is segmented into Hematological Cancers, Solid Tumors and Other Cancers. Based on service provider, the market is segmented into Hospitals & Cancer Centers, Home Healthcare Agencies, Specialty Oncology Providers and Other Providers. Based on payment model, the market is segmented into Public Insurance, Private Insurance and Out-of-Pocket. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Chemotherapy At Home Services Market

An increasing number of cancer patients are opting for chemotherapy treatments at home due to various factors, including the desire to avoid hospital environments, a preference for personalized care, and the convenience of not having to travel frequently. This trend is prompting healthcare providers to enhance their home infusion services, invest in portable delivery systems, and create comprehensive support programs, all of which contribute to the expansion of the market for at-home treatments. Additionally, this shift aligns with the growing adoption of telehealth, facilitating integrated care models that incorporate remote monitoring alongside chemotherapy, which further supports the market's upward trajectory.

Restraints in the Global Chemotherapy At Home Services Market

The provision of chemotherapy services in home settings faces significant barriers due to stringent and varied regulations across different regions, even within the same country. Compliance with these regulations involves meticulous attention to drug handling, proper storage, the employment of qualified healthcare professionals, and adherence to patient safety protocols. This regulatory landscape creates challenges for service providers, as they must navigate complex standards that often require substantial legal knowledge, further training for staff, and expensive changes to their operational procedures. Such challenges can hinder market entry, slow down business growth, and prolong the timeline for launching new programs.

Market Trends of the Global Chemotherapy At Home Services Market

The Global Chemotherapy At Home Services market is witnessing a significant shift as patients increasingly seek convenient oncology care that integrates seamlessly into their daily lives. This trend is propelled by advancements in portable infusion technologies and enhanced pharmacy logistics, which allow for complex chemotherapy regimens to be safely administered in home settings. The growing demand for personalized healthcare experiences, alongside the reduction in travel burdens for patients, is prompting healthcare providers to expand their home-infusion capabilities. As a result, there is a notable investment in specialized home-care teams and partnerships with logistics companies, paving the way for an evolving landscape in cancer treatment delivery.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porter's Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitutes
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Chemotherapy at Home Services Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Home Infusion Chemotherapy
• Oral Chemotherapy Management
• Home-Based Supportive Care
• Other Home Chemotherapy Services

Global Chemotherapy at Home Services Market Size by Care Model & CAGR (2026-2033)

• Market Overview
• Nurse-Led Home Care
• Physician-Supervised Home Care
• Integrated Home Oncology Care

Global Chemotherapy at Home Services Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Hematological Cancers
• Solid Tumors
• Other Cancers

Global Chemotherapy at Home Services Market Size by Service Provider & CAGR (2026-2033)

• Market Overview
• Hospitals & Cancer Centers
• Home Healthcare Agencies
• Specialty Oncology Providers
• Other Providers

Global Chemotherapy at Home Services Market Size by Payment Model & CAGR (2026-2033)

• Market Overview
• Public Insurance
• Private Insurance
• Out-of-Pocket

Global Chemotherapy at Home Services Market Size & CAGR (2026-2033)

• North America (Service Type, Care Model, Cancer Type, Service Provider, Payment Model)
  • US
  • Canada
• Europe (Service Type, Care Model, Cancer Type, Service Provider, Payment Model)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Care Model, Cancer Type, Service Provider, Payment Model)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Care Model, Cancer Type, Service Provider, Payment Model)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Care Model, Cancer Type, Service Provider, Payment Model)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walgreens Boots Alliance, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Option Care Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optum, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amedisys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accredo Health Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations